Endoceutics’s Intrarosa Gets Approval from US FDA
The US FDA approved Intrarosa for the treatment of dyspareunia experienced by women who attained menopause. Dyspareunia is moderate to
Read moreThe US FDA approved Intrarosa for the treatment of dyspareunia experienced by women who attained menopause. Dyspareunia is moderate to
Read moreU.S. regulatory authority Food and Drug Administration on 19th October 2016, granted accelerated approval to Eli Lilly’s Lartruvo, a drug
Read moreUS regulatory authority Food and Drug Administration (FDA) on 13th October 2016, opened a public a consultation on a harmonized
Read moreThe US regulatory authority on 18th Sep approved Exondys 51 (eteplirsen), Sarepta Therapeutics’ initial drug to treat individuals with Duchenne
Read moreUS Food and Drug Administration approved Xiidra, which is lifitegrast ophthalmic solution 5 %,used to treat dry eye disease. Xiidra
Read moreThe U.S. Food and Drug Administration on 27th May accepted Probuphine, the first buprenorphine implant for the maintenance therapy of
Read moreUS Food and Drug Administration (FDA) has chosen to ban most powdered gloves due to the fact that they cause
Read moreThe US FDA on 18th Feb 2016 accepted Briviact (brivaracetam) as an add-on therapy to other drugs to treat partial
Read moreThe U.S. FDA on 23rd Dec 2015 accepted Zurampic (lesinurad) to treat higher levels of uric acid in the blood
Read moreOn 20th Nov 2015 the U.S. FDA provided acceptance for (ixazomib) in combo with two other therapies to treat patients
Read more